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Abstract
Aims/hypothesis We aimed to estimate the lifetime risk of diabetes and diabetes-free life expectancy in metropolitan cities in
India among the population aged 20 years or more, and their variation by sex, age and BMI.
Methods A Markov simulation model was adopted to estimate age-, sex- and BMI-specific lifetime risk of developing diabetes
and diabetes-free life expectancy. The main data inputs used were as follows: age-, sex- and BMI-specific incidence rates of
diabetes in urban India taken from the Centre for Cardiometabolic Risk Reduction in South Asia (2010–2018); age-, sex- and
urban-specific rates of mortality from period lifetables reported by the Government of India (2014); and prevalence of diabetes
from the Indian Council for Medical Research INdia DIABetes study (2008–2015).
Results Lifetime risk (95% CI) of diabetes in 20-year-old men and women was 55.5 (51.6, 59.7)% and 64.6 (60.0, 69.5)%,
respectively. Women generally had a higher lifetime risk across the lifespan. Remaining lifetime risk (95% CI) declined with age
to 37.7 (30.1, 46.7)% at age 60 years among women and 27.5 (23.1, 32.4)% in men. Lifetime risk (95% CI) was highest among
obese Indians: 86.0 (76.6, 91.5)% among 20-year-old women and 86.9 (75.4, 93.8)% among men. We identified considerably
higher diabetes-free life expectancy at lower levels of BMI.
Conclusions/interpretation Lifetime risk of diabetes in metropolitan cities in India is alarming across the spectrum of weight and
rises dramatically with higher BMI. Prevention of diabetes among metropolitan Indians of all ages is an urgent national priority,
particularly given the rapid increase in urban obesogenic environments across the country.
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Introduction
Diabetes is a major global public health problem currently
affecting 463 million individuals and projected to affect 700
million by 2045 [1]. Estimates of prevalence suggest that the
diabetes burden is increasing at a faster pace in low- tomiddle-
income countries (LMICs) than in high-income countries
(HICs). In India, 77 million adults currently have diabetes
and this number is expected to almost double to 134 million
by 2045 [1]. Whereas prevalence estimates are useful for
expressing the overall burden of diabetes at a particular point
in time, they do not inform future risk of developing this
disease at the individual level. Lifetime risk provides an esti-
mate of the cumulative probability of eventually developing
diabetes over the course of life. It is a valuable estimate for
effectively communicating diabetes risk to individuals, even
at young ages, and is also a powerful tool with which to galva-
nise public health and policy responses. The few studies esti-
mating the lifetime risk of developing diabetes are focused on
HICs [2–4]. The population of India, while at the epicentre of
the global diabetes epidemic, has a lower BMI distribution
and lower overall life expectancy; Indian people also show a
comparatively higher propensity to develop diabetes, both at
younger ages and lower BMI levels [5], suggesting a substan-
tially different epidemiology.
Studies from HICs such as the USA [2, 6], Australia [3]
and the Netherlands [4] have found high lifetime risks of
developing diabetes. For example, lifetime risk was 31.3%
among 45-year-old individuals in the USA and 38.0% among
those aged 25 years in the Netherlands. The lifetime risk
among severely obese people in the USA was reported to be
as high as ten times that of underweight individuals [2]. The
combination of a high BMI distribution, high incidence of
diabetes and high life expectancy drive a high overall lifetime
risk in HICs. It is not clear, however, how the lifetime risk of
developing diabetes may differ in LMICs wherein individuals
may have a comparatively lower BMI and life expectancy.
In this study, we estimated the lifetime risk of developing
diabetes in India’s metropolitan cities where an already large
number of adults have diabetes and where there are rapid
increases in population-level weight status and life expectancy
[7]. Drawing on recent diabetes incidence data and on multi-
ple Indian databases, we constructed a Markov model to esti-
mate lifetime risk of diabetes in Indian metropolitan cities and
also stratified by age, sex and BMI. We define metropolitan
cities as per the Indian Census Commission’s definition: cities
with over four million inhabitants (including Delhi, Mumbai,
Kolkata, Chennai, Hyderabad, Bangalore, Ahmedabad, Pune,
Surat and Nashik [8]; making up just over 5% of the popula-
tion around the time of the last census [9]).
Methods
Lifetime risk estimation required, as data inputs, age-, sex-
and BMI-specific estimates of diabetes incidence and age-,
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sex- and BMI-specific rates of mortality by diabetes status.
Differential risks of dying depending on diabetes and weight
status, prevalence of diabetes and the prevalence of different
BMI classes were used to modify population-level rates,
making them specific to particular subgroups (i.e. BMI groups
and individuals with and without diabetes).
This study was approved by the LSHTM Observational/
Interventions Research Ethics Committee (ref. 17568).
Incidence of diabetes Incidence of diabetes was calculated
using data from the India cArdiometabolic Risk Reduction
in South Asia study (CARRS) cohort [10, 11], a metropolitan
based cohort of 9812 participants with high retention and
multiple points of follow-up, representative of Delhi and
Chennai. CARRS was established in 2010–2011 and is under
ongoing follow-up. Fasting venous plasma glucose (FPG) and
HbA1c data were collected at baseline in 2010–2011 as well as
at the second and fourth follow-up assessments in 2013 and
2016, respectively. Age-specific population estimates of inci-
dence were restricted to participants without diabetes at base-
line and the annualised incidence rate was calculated at the
second (2013) and fourth (2016) follow-up assessments.
Incident diabetes was defined as occurring in an individual
reporting no diabetes at baseline and baseline biochemical
variables in the non-diabetes range (FPG <7 mmol/l and
HbA1c< 48 mmol/mol [6.5%]) who subsequently recorded
an FPG ≥7 mmol/l or HbA1c ≥48 mmol/mol (6.5%) or report-
ed diabetes treatment during follow-up. Incidence for the
following age groupswas available: 20–24years; 25–34years;
35–44 years; 45–54 years; 55–64 years; and ≥65 years. Using
the RR of diabetes among different BMI groups, we modified
the population rates to estimate incidence separately for the
underweight/normal weight (BMI <25.0 kg/m2), overweight
(BMI 25.0–29.9 kg/m2) and obese population (BMI ≥30.0 kg/
m2) [12]. We report the incidence rates, in addition to the
number of incident cases, from the CARRS study in the elec-
tronic supplementary material (ESM) Tables 1–5. Incidence
rates by single years were subsequently extracted after fitting a
cubic smoothing spline.
Population mortality rates Mortality rates by 5 year intervals
were extracted from the latest Sample Registration System
(SRS), which contains abridged lifetables for 2013–2017 by
sex and urban residence [13]. The SRS provides conditional
probabilities of death (lifetable notation = nqx), which we used
to obtain age-specific mortality rates using an inversion of
Chiang’s formula [14]. We obtained mortality rates by single
years by fitting an age at death distribution to the 5 year
mortality rates. Specifically, we used the Gompertz–
Makeham law of mortality, which is made up of two separate
components: an age-dependent part that states that the rate of
mortality increases exponentially with age, representing the
underlying mortality age pattern; and a component
independent of age used to account for external causes of
death, which may be especially high in early adulthood [14].
The mortality rates derived from the SRS lifetables are includ-
ed in ESM Table 6 and the fit of the population mortality rates
is shown in the ESM Figs 1–2. From this, we extracted
predicted mortality rates by single years [15].
Differential mortality rates by diabetes and BMI status A
meta-analysis of 35 published articles between 1990 and
2010 (220,689 individuals in HICs, mean follow-up
10.7 years) informed differential mortality rates in individuals
with vs without diabetes. The study found 85% and 100%
higher risk of all-cause mortality among men and women,
respectively, for those with vs without type 2 diabetes [16].
We accounted for differential mortality among populations
with different BMI status by applying RRs of dying by BMI
group from a study that examined the association of BMI with
mortality risk in urban Mumbai between 1991 and 2003 [17].
The study, comprising 148,173 individuals, reported 11%
lower risk and 22% higher risk, of dying among overweight
and obese men aged 35–59 years, respectively, comparedwith
normal-weight men. Furthermore, they identified a 67% and
102% higher risk of death in underweight women and men,
respectively, relative to normal-weight counterparts. Slightly
attenuated RRs were found in individuals aged 60 years or
more. For details of how differential mortality rates were
calculated for the analysis, see ESM Methods.
Age-specific prevalence of diabetes Diabetes prevalence data
were used to compartmentalise population rates of mortality
into a set of rates specific to the population with and without
diabetes. Age-specific diabetes prevalence was obtained from
the Indian Council of Medical Research–INdia DIABetes
(ICMR-INDIAB) study [18]. The ICMR-INDIAB study is
the largest representative study with fasting glucose measures
in India and includes data collected between 2008 and 2015
from 57,117 Indians from 14 states and one Union Territory.
The ICMR-INDIAB study used 8 h fasting capillary blood
glucose (CBG) measured by trained field workers to identify
adults with previously undiagnosed diabetes. CBG is seen as a
reasonable alternative to venous blood glucose in developing
countries and has reasonable sensitivity (83.3–90.9%,
depending on the diagnostic criteria) in India [19]. Using an
82.5 g oral glucose load (equivalent to 75 g of anhydrous
glucose), 2 h post-load CBG was measured in individuals
who did not self-report diabetes. Among those with self-
reported diabetes, only fasting glucose was measured.
Individuals with an 8 h CBG ≥7 mmol/l, 2 h CBG
≥12.2 mmol/l, or both, were categorised as having diabetes.
Age was categorised into groups of 5 years.
Age-specific prevalence of BMI categories We used the
proportion of the urban population in broad BMI categories
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to estimate weighted averages of lifetime risk for the whole
population. The age- and sex-specific prevalences of ‘under-
weight/normal weight’ (BMI <25.0 kg/m2), ‘overweight’ (BMI
25.0–29.9 kg/m2) and ‘obesity’ (BMI ≥30.0 kg/m2) groups
across the whole age range in urban Indians were obtained from
a study that forecasted weight category prevalence in India using
survey data [20]. The study obtained BMI group prevalence
from the 2015–2016 National Family and Health Survey, which
collected nationally representative health and demographic data
on approximately 625,000 adult women aged 15–49 years and
93,000 adult men aged 15–54 years [21]. The Study on global
AGEing and adult health (SAGE) wave 0 (2002–2004) and
wave 1 (2007–2010) were used to obtain estimates of age-
specific proportions of the urban population aged 50 years or
more in broad BMI categories. SAGE is a nationally represen-
tative health and demographic study containing information on
2559 adults in wave 0 and approximately 3000 men and 3000
women in wave 1 [22].
The modelWe adopted a multistateMarkovmodel to estimate
the lifetime risk of diabetes [23]. A detailed and formal
description of the methodology we adopted is described in a
similar study [2]. The multistate model compartmentalises a
population into three separate age-, sex- and BMI-specific
groups: no diabetes; diabetes; and dead. The single-year inci-
dence and mortality rates were inputted into a matrix of rates
of which the exponential was subsequently taken to obtain a
matrix of transition probabilities between the states based on
starting age and state. This was performed separately by BMI
category. These single-year transition probabilities, derived
from the variables, simulated movements between the three
mutually exclusive states (ESM Fig. 3) and the resultant tran-
sition matrix was used to generate measures of both lifetime
risk of developing diabetes and diabetes-free life expectancy
by single years. We were able to calculate total lifetime risk of
developing diabetes as a weighted average of separate lifetime
risk estimates for different BMI groups.
We performed multiple sensitivity analyses. First, we
performed multiple simulations whereby we simultaneously
selected random variables estimates from the distributions that
informed their uncertainty. In total, 5000 simulations were
carried out and the median lifetime risk estimate was reported
as the final point estimate; the range of values at any age
informed the uncertainty interval. Second, we supplemented
our main lifetime risk estimates by BMI using South Asian-
specific BMI cut-offs (BMI <23.0 kg/m2 for the underweight/
normal-weight group, BMI ≥23.0 kg/m2 to <27.5 kg/m2 for the
overweight group and BMI ≥27.5 kg/m2 for the obese group
[24]). The higher positive relationship between body fat and
BMI observed in South Asians when compared with white
Europeans may make use of conventional BMI cut-offs inap-
propriate and lead to a relatively high disease risk at compara-
tively lower body weight [24]. Third, we tested the sensitivity
of our model to the initial prevalence of diabetes (to modify
diabetes and non-diabetes-specific mortality) using age-specific
diabetes prevalence reported for the two Indian cities in the
CARRS study, which used FPG rather than CBG used in the
ICMR-INDIAB study, to determine diabetes status [25]. We
also estimated the lifetime risk of developing diabetes using
incidence rates that omitted HbA1c in diagnosing diabetes. As
individuals with incident diabetes can have normal FPG while
having HbA1c ≥48 mmol/mol (6.5%), this may have led us to
overestimate the main lifetime risk estimates as they may repre-
sent a group with higher glucose tolerance than those satisfying
both FPG and HbA1c-related diagnostic criteria [26]. In addi-
tion to BMI, we also examined the lifetime risk of diabetes by
categories of waist circumference. Finally, we examined the
effect on the total population lifetime risk of a change in the
proportion of urban Indians classified as overweight or obese.
Age-specific forecasts of the prevalence of excessive weight
and obesity in urban India were extracted from a recent study
[20]. All analyses were performed using the R (version 3.6.2)
statistical software package (available for download at https://
cran.r-project.org/bin/windows/base/old/3.6.2/).
Results
Main findings Overall, the lifetime risk (95% CI) of develop-
ing diabetes among Indian metropolitans at age 20 years was
64.6 (95% CI 60, 69.5)% among women and 55.5 (51.6,
59.7)% among men. At ages 40 and 60 years, the remaining
lifetime risk (95% CI) among women was 59.2 (52.4, 64.9)%
and 37.7 (30.1, 46.7)%, respectively, and among men aged 40
and 60 years was 47.3 (42.4, 52.3)% and 27.5 (23.1, 32.4)%,
respectively (Table 1).
As expected, we found a higher age-specific lifetime risk of
developing diabetes in higher BMI groups compared with
lower ones. At age 20 years, the lifetime risk (95% CI) of
developing diabetes among underweight/normal-weight men
was 41.2 (36.7, 45.7)% compared with 71.3 (64.6, 77.6)%
among overweight men and 86.9 (75.4, 93.8)% among obese
men. Similarly, at age 20 years, the lifetime risk (95% CI) of
developing diabetes among underweight/normal-weight
women was 51.6 (46.0, 58.4)% compared with 71.0 (61.0,
80.6)% and 86.0 (76.6, 91.5)% among overweight and obese
women, respectively.
Across BMI groups, the largest difference in lifetime risk
of developing diabetes was between underweight/normal
weight and overweight individuals. To illustrate, among urban
men aged 20 years, the lifetime risk was higher by approxi-
mately 30 percentage points in the overweight group (71.3%)
compared with the underweight/normal weight group
(41.2%), whereas the lifetime risk was around 15 percentage
points higher in obese men aged 20 years (86.9%) when
compared with overweight counterparts.
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Women at age 20 years can expect to live 38.9 of their
remaining 54.4 years spent free of diabetes (71.6% of their
remaining life) (Table 2). Similarly, men aged 20 years can
expect to live 39.9 years of their remaining 52.6 years free of
diabetes (75.9%). The remainder of life spent with diabetes
varied considerably between BMI groups. Among
underweight/normal weight women aged 20 years, on aver-
age, 43.4 years of an expected 54.5 remaining years (79.6%)
were estimated to be diabetes-free, compared with 27.1 years
of the remaining 52.4 years of life of obese women aged
20 years (51.8%).
Sensitivity analysis findings As expected, the overall life-
time risk of developing diabetes was attenuated when
using South Asian-specific BMI cut-offs (Table 3). To
illustrate, at age 20 years, the lifetime risk (95% CI) of
developing diabetes was 37.4 (33.1, 44.3)% among
underweight/normal-weight men, 63.6 (55.6, 71.9)%
among overweight men and 83.3 (73, 91.1)% among
obese men. For women aged 20 years, the lifetime risk
(95% CI) was 46.8 (41.4, 53.0)% among underweight/
normal-weight women, 67.6 (56.9, 75.2)% among over-
weight women and 80.3 (69.5, 88.3)% among obese
women. We also assessed the effect of using age-specific
prevalence of diabetes from CARRS, rather than the
ICMR-INDIAB prevalence. The effect of this on the life-
time risk estimates was negligible (a change of 0–1
percentage points compared with initial estimates).
When using incidence rates that excluded HbA1c in the
determination of incident diabetes, we identified slightly
different, although not notable, lifetime risk estimates (ESM
Table 2 Percentage of remaining life spent with diabetes in Indian metropolitan cities by global BMI cut points at ages 20, 40 and 60
BMI group Men Women
Life expectancy
(years)
Diabetes-free life
expectancy (years)
% of remaining
life without diabetes
Life
expectancy (years)
Diabetes-free
life expectancy
(years)
% of remaining
life without
diabetes
Underweight/normal weight (BMI <25 kg/m2)
Age 20 years 52.8 44.7 84.7 54.5 43.4 79.6
Age 40 years 34.4 28.8 83.5 35.7 27.6 77.2
Age 60 years 17.6 15.6 88.8 18.1 15.4 84.9
Overweight (BMI ≥25 kg/m2 to <30 kg/m2)
Age 20 years 51.5 34.8 67.4 53.9 36.2 67.1
Age 40 years 33.6 22.2 66.2 35.2 23.0 65.3
Age 60 years 17.3 13.1 76.0 17.9 13.6 76.1
Obese (BMI ≥30 kg/m2)
Age 20 years 49.3 22.6 45.7 52.4 27.1 51.8
Age 40 years 32.3 15.4 47.7 34.2 17.8 51.9
Age 60 years 17.3 11.1 64.1 17.6 11.6 65.9
Total population
Age 20 years 52.6 39.9 75.9 54.4 38.9 71.6
Age 40 years 34.3 25.5 74.2 35.6 24.4 68.4
Age 60 years 17.7 15.1 85.3 18.2 14.7 80.7
Table 1 Lifetime risk of developing diabetes by global BMI cut points
in Indian metropolitan cities
BMI group Lifetime risk
Men Women
Underweight/normal weight (BMI <25 kg/m2)
Age 20 years 41.2 (36.7, 45.7) 51.6 (46, 58.4)
Age 40 years 34.5 (30.7, 38.8) 47.1 (40.5, 54.6)
Age 60 years 21.5 (16.7, 27.5) 30.7 (23.2, 40.1)
Overweight (BMI ≥25 kg/m2 to <30 kg/m2)
Age 20 years 71.3 (64.6, 77.6) 71.0 (61.0, 80.6)
Age 40 years 63.8 (54.0, 72.1) 64.9 (54.1, 77.8)
Age 60 years 44.9 (32.2, 56.1) 45.9 (30.8, 65.6)
Obese (BMI ≥30 kg/m2)
Age 20 years 86.9 (75.4, 93.8) 86.0 (76.6, 91.5)
Age 40 years 77.2 (56.7, 87.8) 79.1 (65.6, 88.8)
Age 60 years 55.9 (34.1, 74.6) 58.5 (32.9, 78.6)
Total population
Age 20 years 55.5 (51.6, 59.7) 64.6 (60.0, 69.5)
Age 40 years 47.3 (42.4, 52.3) 59.2 (52.4, 64.9)
Age 60 years 27.5 (23.1, 32.4) 37.7 (30.1, 46.7)
Lifetime risk is presented as % (95% CI)
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Table 7). Overall lifetime risk (95%CI) at age 20 years among
men and women, respectively, was 55.0 (51.1, 58.7)% and
59.2 (54.9, 63.7)% and decreased to 29.0 (25.0, 33.5)% and
32.8 (27.5, 37.7)% at age 60 years. Again, this masked consid-
erable variation by BMI, whereby the lifetime risk (95%CI) at
age 20 years in men and women, respectively, was as follows:
40.0 (36.4, 43.3)% and 40.6 (35.9, 45.2)% among
underweight/normal-weight individuals; 69.9 (63.7, 75.1)%
and 69.3 (62.8, 75.2)% among overweight individuals; and
88.9 (82.2, 93.3)% and 85.3 (77.3, 92.4)% among obese
individuals.
We also estimated lifetime risks of developing diabetes
according to waist circumference. At age 20 years, the lifetime
risk (95% CI) was 71.0 (64.4, 80.9)% for men with a waist
circumference ≥90 cm and 45.2 (40.9, 48.8)% for men with a
waist circumference <90 cm (ESM Table 8). Among women
aged 20 years, the lifetime risk (95% CI) was 75.5 (65.2,
84.2)% for those with waist circumference ≥80 cm and 44.5
(39.6, 49.4)% for those with waist circumference <80 cm.
Using the 2040 forecasted BMI group distribution in urban
India, we estimated that the overall lifetime risk (95% CI) of
developing diabetes among individuals aged 20 years would
increase to 64.0 (60.0, 66.8)% and 77.1 (71.0, 81.7)% for men
and women, respectively (ESM Table 9).
Discussion
We found that in metropolitan India, the lifetime risk of devel-
oping diabetes among women and men without diabetes at
age 20 years was 64.6% and 55.5%, respectively. The lifetime
risk was consistently higher among women compared with
men and declined with age. Two in five underweight/
normal-weight 20-year-old men and over half of the
underweight/normal-weight 20-year-old women were
projected to develop diabetes, and the remaining risk
increased to over eight in ten among obese individuals aged
20 years. We also found that obese metropolitans can expect
to spend the greatest percentage of their remaining life with
diabetes (around 50% from age 20 years).
These estimations relied on a number of assumptions. First,
the model assumed that BMI-specific age-specific diabetes
incidence will be constant throughout the lifetime of the
cohort. This is a reasonable assumption given the lack of
evidence as to how future BMI-specific diabetes incidence
will develop. Second, we assumed that the transition to diabe-
tes is permanent and that an individual cannot transition back
to not having diabetes, an assumption we decided was reason-
able given the relative rarity of spontaneous remission from
diabetes. Third, we assumed that the RR of dying among those
with diabetes relative to those without will remain constant
into the future. The extent to which results changed through
relaxation of this assumptions was negligible.
Our study has a number of strengths. Blood tests were used
to identify diabetes and BMI was also objectively measured
rather than using self-reports. Studies assessing the validity of
self-reported diabetes have found considerable misclassifica-
tion. For instance, one study found a sensitivity of self-
reported diabetes in China was around 58.2% in urban areas
and 35.0% in rural areas [27]. Low sensitivity of self-reported
diabetes has the potential to underestimate the lifetime risk
estimates of previous studies [2], potentially explaining differ-
ences between ours and previous findings from different
settings. We also used data sources that are designed to be
geographically representative to measure mortality rates,
BMI and diabetes. As data on national-level incidence of
diabetes are not available, we obtained incidence rates from
a large well-characterised, well-retained and followed up,
representative cohort in urban areas of North and South
India, making our results both geographically representative
and generalisable to the wider metropolitan population.
Finally, we performed extensive sensitivity analyses,
reporting a range of uncertainty around our estimates, provid-
ing supplementary lifetime risk estimates using South Asian-
specific BMI cut-offs, accommodating for potential overesti-
mation of diabetes incidence when using HbA1c by using
solely FPG and diabetes treatment to classify diabetes cases,
and examining the sensitivity of the estimates to initial diabe-
tes prevalence by using diabetes prevalence estimated in the
CARRS cohort.
Our study also has a number of limitations. First, assuming
that age-specific rates will prevail over the projection period
may have led us to both underestimate lifetime risk of diabetes
within a BMI group (as the individual BMI distribution within
Table 3 Lifetime risk of developing diabetes by South Asian BMI cut
points in Indian metropolitan cities
BMI group Lifetime risk
Men Women
Underweight/normal weight (BMI <23 kg/m2)
Age 20 years 37.4 (33.1, 44.3) 46.8 (41.4, 53.0)
Age 40 years 32.0 (27.5, 39.2) 42.2 (36.0, 48.8)
Age 60 years 20.3 (15.2, 28.3) 27.0 (20.8, 34.6)
Overweight (BMI ≥23 kg/m2 to <27.5 kg/m2)
Age 20 years 63.6 (55.6, 71.9) 67.6 (56.9, 75.2)
Age 40 years 55.7 (46.9, 64.8) 63.1 (51.3, 71.9)
Age 60 years 37.8 (25.5, 49.4) 44.2 (31.1, 56.8)
Obese (BMI ≥27.5 kg/m2)
Age 20 years 83.3 (73.0, 91.1) 80.3 (69.5, 88.3)
Age 40 years 73.8 (60.8, 83.4) 72.1 (59.6, 83.7)
Age 60 years 53.5 (31.5, 71.8) 49.5 (29.3, 72.6)
Lifetime risk is presented as % (95% CI)
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a broad BMI group shifts to the right) and underestimate the
overall lifetime risk for the total population (as the prevalence
of excessive weight and obesity has increased in recent
decades [21], and will likely increase into the future). One
study in the USA identified increases in overall population
lifetime risk of 20 and 13 percentage points in men and
women, respectively between 1985 and 2011 [6]. The latter
concern was addressed in sensitivity analysis using forecasted
prevalence of excessive weight and obesity in urban India.
Second, life expectancy at all ages in India is expected to
continue to increase over the coming years [28]. Longer life
expectancies may increase the lifetime risk of diabetes,
making our results possible underestimates. Third, the socio-
economic distribution of excessive weight and obesity is like-
ly to continue to change. A recent study has documented an
increasing proportion of the overweight and obese population
coming from lower socioeconomic backgrounds [29] among
whom the RR of dying compared with people from higher
socioeconomic backgrounds is likely to be higher. This may
have led us to potentially overestimate the lifetime risk for the
obese people. Our results should be interpreted with some
caution, especially given India’s considerable heterogeneity,
somewhat limiting the generalisability of our findings to all of
urban India. The results from this study relate to an average
urban-dwelling individual in two highly urbanised areas;
however, the extent of variation in lifetime risk and years of
life lost to diabetes will depend on how much a particular
individual differs from this average in regards their risk of
diabetes [2, 30].
To our knowledge, this is the only study estimating the
lifetime risk of diabetes in urban India. A comparison of
our findings from those reported in HICs indicates an
alarmingly high lifetime risk at every age in urban India.
Recent data from the Netherlands indicates a 31.3% life-
time risk of diabetes among 45-year-olds; this contrasts
with the reported 53.8% in urban Indian men and 55.4%
in urban Indian women of the same age [4]. A study from
the USA, using data from 2000–2011, reported a lifetime
risk of diabetes of 40.2% among men and 39.6% among
women aged 20 years. Our results are much closer to
estimates of lifetime risk of diabetes among the black
and Hispanic populations in the USA, groups considered
at a higher risk of developing diabetes than the general
population. A recent study found lifetime risks of devel-
oping diabetes in excess of 55.2% among black women
and 51.5% in Hispanic women aged 20 years in the USA
[6]. The higher lifetime risk among black and Hispanic
women in the USA is driven by higher incidence when
compared with white women. A study of diabetes inci-
dence comparing urban Indian adults with black and white
US residents reported consistently higher incidence in
urban South Asians at all ages and BMI levels [11].
Overall, we posit that the considerably higher lifetime risk
is driven by a relatively high predisposition to developing
diabetes among Indians at both lower ages (up to a
decade earlier) and lower BMIs when compared with
white European populations [5].
On average, 70.1% of the remaining lifespan of the average
woman and 74.0% of the remaining life of the average man
without diabetes at the age of 20 years can be expected to be
spent diabetes free; this proportion decreases considerably
with increasing BMI. Attenuated results have been found in
HICs; one study reported that Australians aged 25 years will
spend 86% of their remaining years diabetes free [3], whereas
a USA-based study found that women aged 18 years who
were obese and severely obese could expect to spend around
80% and 65%, respectively, of their remaining life diabetes
free [2].
The remarkably high lifetime risk of developing diabetes
and the low diabetes-free life expectancy in urban India, espe-
cially for individuals with high BMI, implies that interven-
tions targeting the incidence of diabetes may be of paramount
importance moving forward. The importance is reinforced by
the early onset of diabetes among South Asians, implying a
greater proportion of life spent with diabetes and greater expo-
sure to diabetes-related complications. Potentially effective
interventions include high and sustained sugar-sweetened
beverage taxation [31] or diabetes prevention programmes
involving a combination of culturally tailored lifestyle inter-
ventions with a course of medication [32]. The success of any
intervention will also require improved detection of individ-
uals with diabetes and either impaired glucose tolerance or
impaired fasting glucose, given that an estimated 57% of
diabetes cases are undiagnosed in India [1]. Although in
India the advancement from either impaired glucose tolerance
or impaired fasting glucose to diabetes has been found to be
comparatively faster than in other populations [7, 33], any
level of insulin resistance adds to a very sobering picture of
dysglycaemia and associated complications in a country
where urban obesogenic environments are on the increase
and public health infrastructure is strained. Additional strain
is also likely to be exerted on individual families as personal
expenditure on diabetes care can be as high as 34% of house-
hold income for some low-income urban families [34].
Metropolitan Indians at every age and BMI have an
alarmingly high probability of developing diabetes
compared with results from HICs, necessitating a strong
demand for proactive efforts to prevent diabetes in
metropolitan cities, given the rapid increase in urban
obesogenic environments across the country [35].
Prevention of diabetes, especially in younger metropoli-
tan Indians, should be a high priority for India. Future
research into rural lifetime risks of diabetes, using
diabetes incidence rates from such settings, is encour-
aged to provide a more complete snapshot of the overall
lifetime risk of diabetes at the national level.
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